drug

SummaryAfter more than 6 months in the doldrums, one of the world’s largest trials of COVID-19 treatments is finally restarting. Solidarity, a global study led by the World Health Organization, will test three new drugs in hospitalized…

Screening for drugs that don't workIn the battle against COVID-19, drugs discovered in repurposing screens are of particular interest because these could be rapidly implemented as treatments. However, Tummino et al. deliver a cautionary…

SummaryIn the wake of the controversial U.S. regulatory approval of the Alzheimer's drug aducanumab, physicians expect many patients with memory problems will want to know whether they are eligible. But a definitive diagnosis is expensive…

SummaryThe antibody aducanumab this week became the first new Alzheimer's disease drug approved in the United States since 2003, and the first ever that aims to interfere with the underlying disease process. In a controversial decision, the…